Cargando…

Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()

Radiotherapy (XRT) delivered with the antibody cetuximab is a standard treatment option for squamous cell carcinomas of head and neck (SCCNH). Cetuximab acts by blocking epidermal growth factor receptor (EGFR) signaling to inhibit cancer progression. However, a significant percentage of patients wil...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Llobet, Lara I., Baro, Marta, Mesia, Ricard, Balart, Josep
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202798/ https://www.ncbi.nlm.nih.gov/pubmed/25171892 http://dx.doi.org/10.1016/j.tranon.2014.02.008

Ejemplares similares

Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours
por: Baro, M, et al.
Publicado: (2014)

PARP inhibitor Olaparib increases the sensitization to radiotherapy in FaDu cells
por: Liu, Chuan, et al.
Publicado: (2020)

Effect of celecoxib on inhibiting tumor repopulation during radiotherapy in human FaDu squamous cell carcinoma
por: Yang, Jia, et al.
Publicado: (2014)

Capsaicin-Induced Apoptosis of FaDu Human Pharyngeal Squamous Carcinoma Cells
por: Le, Thanh-Do, et al.
Publicado: (2012)

In vitro cytotoxicity of GO–DOx on FaDu squamous carcinoma cell lines
por: Singh, Manjri, et al.
Publicado: (2018)

Role and mechanism of Twist1 in modulating the chemosensitivity of FaDu cells
por: LU, SUMEI, et al.
Publicado: (2014)

The effect and mechanism of action of metformin on in vitro FaDu cell proliferation
por: Sun, Ruijie, et al.
Publicado: (2016)

Demethoxycurcumin induces apoptosis via inhibition of NF-κB pathway in FaDu human head and neck squamous cell carcinoma
por: Lee, Gyeong-Je, et al.
Publicado: (2022)

Stathmin1 overexpression in hypopharyngeal squamous cell carcinoma: A new promoter in FaDu cell proliferation and migration
por: Chen, Yan, et al.
Publicado: (2016)

The Limitations of Collagen/CPP Hybrid Peptides as Carriers for Cancer Drugs to FaDu Cells
por: Ho, Kevin, et al.
Publicado: (2019)

(+)-Usnic acid modulates the Nrf2-ARE pathway in FaDu hypopharyngeal carcinoma cells
por: Krajka-Kuźniak, Violetta, et al.
Publicado: (2021)

Arctigenin induces caspase-dependent apoptosis in FaDu human pharyngeal carcinoma cells
por: Kang, Kyeong-Rok, et al.
Publicado: (2022)

Influence of 2-Nitroimidazoles in the Response of FaDu Cells to Ionizing Radiation and Hypoxia/Reoxygenation Stress
por: Rashed, Faisal Bin, et al.
Publicado: (2023)

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019)

Identification of Two New Phenanthrenes from Dendrobii Herba and Their Cytotoxicity towards Human Hypopharynx Squamous Carcinoma Cell (FaDu)
por: Nam, Bomi, et al.
Publicado: (2019)

Different levels of let-7d expression modulate response of FaDu cells to irradiation and chemotherapeutics
por: Lamperska, Katarzyna Monika, et al.
Publicado: (2017)

The use of matrigel has no influence on tumor development or PET imaging in FaDu human head and neck cancer xenografts
por: Fliedner, Frederikke P., et al.
Publicado: (2016)

Downregulation of RNA binding motif protein 17 expression inhibits proliferation of hypopharyngeal carcinoma FaDu cells
por: Han, Yuefeng, et al.
Publicado: (2018)

Identification of differentially expressed genes associated with the enhancement of X-ray susceptibility by RITA in a hypopharyngeal squamous cell carcinoma cell line (FaDu)
por: Luan, Jinwei, et al.
Publicado: (2016)

Lovastatin causes FaDu hypopharyngeal carcinoma cell death via AMPK-p63-survivin signaling cascade
por: Yen, Chia-Sheng, et al.
Publicado: (2016)

Metformin Suppresses Hypopharyngeal Cancer Growth by Epigenetically Silencing Long Non-coding RNA SNHG7 in FaDu Cells
por: Wu, Ping, et al.
Publicado: (2019)

Adenosine induces intrinsic apoptosis via the PI3K/Akt/mTOR signaling pathway in human pharyngeal squamous carcinoma FaDu cells
por: Choi, Mi Suk, et al.
Publicado: (2019)

TBX3 knockdown suppresses the proliferation of hypopharyngeal carcinoma FaDu cells by inducing G1/S cell cycle arrest and apoptosis
por: Huang, Yongjiu, et al.
Publicado: (2020)

The use of caspase inhibitors in pulsed-field gel electrophoresis may improve the estimation of radiation-induced DNA repair and apoptosis
por: Balart, Josep, et al.
Publicado: (2011)

AGO2 involves the malignant phenotypes and FAK/PI3K/AKT signaling pathway in hypopharyngeal-derived FaDu cells
por: Zhang, Yanhui, et al.
Publicado: (2017)

Analysis of ceRNA network of differentially expressed genes in FaDu cell line and a cisplatin-resistant line derived from it
por: Zhang, Gehou, et al.
Publicado: (2021)

Erratum to "Capsaicin-Induced Apoptosis of FaDu Human Pharyngeal Squamous Carcinoma Cells" by Le TD, et al. (Yonsei Med J 2012;53:834-41.)
Publicado: (2012)

5-aza-2’-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line
por: Miari, Reem, et al.
Publicado: (2021)

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
por: Guigay, Joël, et al.
Publicado: (2019)

Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
por: Brú, Antonio, et al.
Publicado: (2009)

NVP-BEZ235, a dual PI3K-mTOR inhibitor, suppresses the growth of FaDu hypopharyngeal squamous cell carcinoma and has a synergistic effect with Cisplatin
por: Hsu, Cheng-Ming, et al.
Publicado: (2018)

Fadu head and neck squamous cell carcinoma induces hyperexcitability of primary sensory neurons in an in vitro coculture model
por: Uhelski, Megan L., et al.
Publicado: (2022)

Review of cetuximab in the treatment of squamous cell carcinoma of the head and neck
por: Merlano, Marco, et al.
Publicado: (2007)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

Overexpression of microRNA-107 suppressed proliferation, migration, invasion, and the PI3K/Akt signaling pathway and induced apoptosis by targeting Nin one binding (NOB1) protein in a hypopharyngeal squamous cell carcinoma cell line (FaDu)
por: Gao, Xin, et al.
Publicado: (2022)

TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
por: Rubió-Casadevall, Jordi, et al.
Publicado: (2023)

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Charalambakis, Nikolaos, et al.
Publicado: (2013)

Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck
por: Knutzen, Greg, et al.
Publicado: (2015)

Biomarkers of cetuximab resistance in patients with head and neck squamous cell carcinoma
por: Leblanc, Olivia, et al.
Publicado: (2020)

Concurrent Radiotherapy with Carboplatin and Cetuximab for the Treatment of Medically Compromised Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma
por: Saigal, Kunal, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2pnad22jqdaaaecnsf5ji8glh6